DAGLA
Basic information
Region (hg38): 11:61680391-61747001
Previous symbols: [ "C11orf11" ]
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Neuroocular syndrome 2, paroxysmal type | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 35737950 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (84 variants)
- not_provided (33 variants)
- DAGLA-related_disorder (18 variants)
- Benign_paroxysmal_tonic_upgaze_of_childhood_with_ataxia (7 variants)
- Autism (1 variants)
- Autosomal_dominant_cerebellar_ataxia (1 variants)
- not_specified (1 variants)
- Attention_deficit_hyperactivity_disorder (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DAGLA gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006133.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 17 | 20 | ||||
| missense | 96 | 10 | 108 | |||
| nonsense | 6 | |||||
| start loss | 0 | |||||
| frameshift | 8 | |||||
| splice donor/acceptor (+/-2bp) | 3 | |||||
| Total | 5 | 2 | 106 | 27 | 5 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| DAGLA | protein_coding | protein_coding | ENST00000257215 | 19 | 66569 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.00 | 0.0000105 | 125735 | 0 | 7 | 125742 | 0.0000278 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 4.01 | 402 | 700 | 0.574 | 0.0000494 | 6687 |
| Missense in Polyphen | 136 | 328.41 | 0.41412 | 3149 | ||
| Synonymous | -0.0920 | 317 | 315 | 1.01 | 0.0000237 | 2217 |
| Loss of Function | 5.83 | 3 | 45.4 | 0.0660 | 0.00000213 | 505 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000289 | 0.0000289 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000547 | 0.0000544 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000451 | 0.0000439 |
| Middle Eastern | 0.0000547 | 0.0000544 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the hydrolysis of diacylglycerol (DAG) to 2- arachidonoyl-glycerol (2-AG), the most abundant endocannabinoid in tissues. Required for axonal growth during development and for retrograde synaptic signaling at mature synapses. {ECO:0000269|PubMed:14610053}.;
- Pathway
- Aldosterone synthesis and secretion - Homo sapiens (human);Retrograde endocannabinoid signaling - Homo sapiens (human);Cell-type Dependent Selectivity of CCK2R Signaling;Cannabinoid receptor signaling;Signaling by GPCR;Signal Transduction;Effects of PIP2 hydrolysis;Platelet activation, signaling and aggregation;Arachidonate production from DAG;Hemostasis;G alpha (q) signalling events;GPCR downstream signalling;N-cadherin signaling events
(Consensus)
Recessive Scores
- pRec
- 0.120
Intolerance Scores
- loftool
- 0.141
- rvis_EVS
- -0.57
- rvis_percentile_EVS
- 18.96
Haploinsufficiency Scores
- pHI
- 0.393
- hipred
- Y
- hipred_score
- 0.655
- ghis
- 0.546
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.369
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dagla
- Phenotype
- normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- dagla
- Affected structure
- retinal ganglion cell
- Phenotype tag
- abnormal
- Phenotype quality
- hypoplastic
Gene ontology
- Biological process
- G protein-coupled glutamate receptor signaling pathway;neuroblast proliferation;arachidonic acid metabolic process;neurogenesis;neurotransmitter biosynthetic process;diacylglycerol catabolic process;endocannabinoid signaling pathway;retrograde trans-synaptic signaling by endocannabinoid
- Cellular component
- plasma membrane;varicosity;postsynaptic membrane;integral component of postsynaptic membrane
- Molecular function
- metal ion binding;acylglycerol lipase activity